Purple Biotech (PPBT) Notes Payables (2014 - 2020)
Purple Biotech (PPBT) posted quarterly Notes Payables of $24.4 million for Q2 2020, up 895.63% year-over-year from $2.5 million in Q3 2019, and up 895.63% quarter-over-quarter from $2.5 million in Q2 2019.
Purple Biotech (PPBT) Notes Payables (2014 - 2020) Analysis & Trends
Purple Biotech (PPBT) has reported Notes Payables for 5 consecutive years, with $24.4 million the latest figure, recorded in Q2 2020.
- In Q2 2020, Notes Payables rose 895.63% year-over-year to $24.4 million; the TTM figure through Jun 2020 stood at $24.4 million (up 895.63% YoY), while the FY2018 annual figure was $554000.0, down 72.47% from the prior year.
- Notes Payables advanced to $24.4 million in Q2 2020 per PPBT's latest filing, from $2.5 million in the prior quarter.
- Across five years, Notes Payables topped out at $24.4 million in Q2 2020 and bottomed at $554000.0 in Q4 2018.
- Historically, Notes Payables has averaged $5.8 million across 4 years, with a median of $2.2 million in 2017.
- Annual changes were most pronounced in 2018 — Notes Payables slumped 72.47% — and 2020, when it surged 895.63%.
- Purple Biotech's Notes Payables stood at $2.0 million in 2017, then plunged by 72.47% to $554000.0 in 2018, then soared by 342.42% to $2.5 million in 2019, then soared by 895.63% to $24.4 million in 2020.
- Business Quant data shows PPBT's Notes Payables at $24.4 million in Q2 2020, $2.5 million in Q2 2019, and $554000.0 in Q4 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Purple Biotech | 133.62 | 133.62 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2020 | 24.40 Mn |
| Jun 30, 2019 | 2.45 Mn |
| Dec 31, 2018 | 554,000.00 |
| Jun 30, 2018 | 4.32 Mn |
| Dec 31, 2017 | 2.01 Mn |
| Jun 30, 2017 | 1.00 Mn |
| Dec 31, 2014 | 294,000.00 |
| Sep 30, 2014 | 294,000.00 |